In 2002, the EMA issued a position paper where serum (not plasma) thromboxane B 2 determination was the only assay required for the authorization of new low-dose aspirin formulations ...

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

emphasizing the significance of early aspirin use administration in the ICU. A retrospective cohort analysis was conducted utilizing the Medical Information Mart for Intensive Care IV (MIMIC-IV), a ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

This analysis included a total of 48,422 patients ... The authors conclude that an initial aspirin dose of 162 mg may be as effective as, and possibly safer than, a 325 mg dose in patients ...

Aspirin is widely used in the secondary prevention of coronary events. A recent study by Ferrari and colleagues indicates that its withdrawal increases the risk of a new coronary event. This ...

This study aimed to investigate the efficacy of aspirin use among VSA patients. Design Systematic review and meta-analysis. Data sources PubMed, Web of Science and Cochrane Central Register of ...

A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...

The sensitivity analysis provided insights into the potential impact of missing data handling methods on the study conclusions, ensuring a comprehensive assessment of the study’s validity. A total of ...

Safety: Aspirin was well-tolerated, with no major safety concerns reported. The ASCOLT trial showed that aspirin did not ...